CASE STUDY · HEALTHCARE
Teledermatology platform for case management
PocketDerma is a secure teledermatology platform for asynchronous case management, from case submission and payment to clinical review and signed treatment recommendations.
Industry
Healthcare
Client
PocketDerma
Solution
Teledermatology web platform
Delivery
Functional MVP in 3 months
See PocketDerma in action
Watch the video to see how PocketDerma supports secure case submission, clinical review, and signed treatment recommendations in one asynchronous teledermatology workflow.
01 — Context
Dermatology guidance is not always easy to access when it is needed.
People seeking dermatology guidance may face long waits or limited local access to a specialist. For non-urgent skin concerns, collecting symptoms, photographs, and relevant history is an important part of enabling a clinician to review a case remotely.
Teledermatology creates a way to structure that information before a consultation. It brings together patient evidence, clinician review, communication, and follow-up records in a digital case workflow.
02 — Problem
Remote dermatology cases needed a secure, structured path from submission to clinical guidance.
A remote dermatology interaction involves more than sending a photo. The process needs enough case information for review, a secure way to handle sensitive images, a payment step, access to an available licensed dermatologist, and a clear record of the clinical exchange.
PocketDerma needed a solution that could coordinate the case lifecycle while giving patients a clear way to submit information and allowing dermatologists to request further evidence before issuing a signed treatment recommendation.
03 — Solution
A teledermatology platform designed around the lifecycle of a clinical case.
Patients create an account, describe a skin concern, attach images, and pay for clinical review. After payment, the platform assigns the case to an available licensed dermatologist, who can review evidence, communicate through case chat, request additional details, and issue a signed treatment recommendation.
01. Case Submission and Payment
Patients create a case with a problem summary, structured details, and photographs. The platform validates the required information before payment for clinical review.
02. Allocation and Clinical Review
After payment, the platform assigns the case to an available licensed dermatologist. The doctor receives the case context and begins review.
03. Evidence and Recommendation
The dermatologist and patient communicate through case chat. When necessary, the doctor can request additional photographs, videos, symptoms, or history before issuing a signed treatment recommendation.
04. History and Administration
Patients retain access to case history and downloadable recommendations. Administrators oversee users, case flow, and payment configuration without compromising privacy.
04 — Engineering
Designed to protect sensitive clinical case data.
PocketDerma was implemented as an Angular single-page web application connected to Spring REST microservices and Google Cloud Platform infrastructure. The architecture supports the interaction between patients, dermatologists, and administrators across the full case workflow.
The solution design followed security protocols for safeguarding sensitive clinical data.
Private Media Access and Case Data
Sensitive dermatology images and case content are private by default, with secure storage and transmission across the platform.
Traceable Case Lifecycle
The platform records submission, payment, allocation, recommendation, and closure events, providing a clear history for the case workflow.
Role-Based Workflows
Role-based permissions support the different responsibilities of patients, dermatologists, and administrators across the platform.
05 — Results
A functional MVP that validated the core teledermatology workflow.
Two developers delivered PocketDerma as a functional MVP in approximately three months. The product was piloted with a small user group to validate remote case submission, dermatologist collaboration, and signed recommendation delivery.
Functional MVP
Two developers delivered a functional MVP in approximately three months.
Pilot Validation
A small user group piloted remote case submission, dermatologist collaboration, and signed recommendation delivery.
Core Workflow
The pilot demonstrated the core asynchronous teledermatology workflow from secure submission to clinical recommendation.
Product Status
The product did not achieve the originally envisaged market traction, and further development and commercialization were placed on hold.
Do you have a healthcare software concept?
We can help turn a sensitive, multi-actor healthcare workflow into a secure digital product.
Frequently Asked Questions
What is PocketDerma?
PocketDerma is a secure teledermatology platform for asynchronous case management. It supports case submission, payment, clinical review, communication, and signed treatment recommendation delivery.
How did patients submit a dermatology case?
Patients created an account, described a skin concern, added structured details and photographs, and paid for clinical review after the case information was validated.
How did clinical review work?
After payment, the platform assigned the case to an available licensed dermatologist. The dermatologist reviewed the evidence, communicated through case chat, requested additional information when necessary, and issued a signed treatment recommendation.
How did PocketDerma protect sensitive case data?
Private-by-default media access, secure storage and transmission, role-based permissions, audit logs, and traceable lifecycle events protected sensitive dermatology images and case content.
What technology supported PocketDerma?
PocketDerma used an Angular single-page web application, Spring REST microservices, and Google Cloud Platform infrastructure.
What was the outcome of the PocketDerma MVP?
Two developers delivered a functional MVP in approximately three months and piloted it with a small user group. The core workflow was validated, but the product did not achieve the originally envisaged market traction and was placed on hold.
